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Abstract Accumulation of triacylglycerol (TAG) and lipid
intermediates in skeletal muscle plays an important role in
the etiology of insulin resistance and type 2 diabetes mellitus.
Disturbances in skeletal muscle lipid turnover and lipolysis
may contribute signiWcantly to this. So far, knowledge on the
regulation of muscle lipolysis is limited. Recently the identi-
Wcation of a new lipase was reported: adipose triglyceride
lipase (ATGL). ATGL deWcient animals show signiWcant
lipid accumulation in skeletal muscle, which may indicate
that ATGL plays a pivotal role in skeletal muscle lipolysis.
However, until now, it is still unknown whether ATGL pro-
tein is expressed in human skeletal muscle. Therefore, the
aim of the present study was to investigate whether ATGL is
expressed at the protein level in human skeletal muscle, and
to examine whether its expression is Wber-type speciWc. To
accomplish this, we established an imunohistochemical and
immunoXuorescent staining procedure to study ATGL pro-
tein expression in relation to Wber type in human vastus late-
ralis muscle of eight male subjects (BMI range: 21.0–
34.5 kg/m2 and age: 38–59 years). In the present paper we
report for the Wrst time that ATGL protein is indeed
expressed in human skeletal muscle. Moreover, ATGL is
exclusively expressed in type I (oxidative) muscle Wbers,
suggesting a pivotal role for ATGL in intramuscular fatty
acid handling, lipid storage and breakdown.
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Introduction
The prevalence of obesity and type 2 diabetes mellitus has
reached epidemic proportions both in developing as well as
developed countries. More information is required on the
etiology of obesity and insulin resistance to improve nutri-
tional recommendations and/or to identify new targets for
pharmacological interventions. Recent evidence indicates
that increased storage of triacylglycerol (TAG) and lipid
intermediates in non-adipose tissues (i.e. ectopic fat deposi-
tion), such as skeletal muscle plays an important role in the
etiology of insulin resistance and type 2 diabetes mellitus
(Petersen and Shulman 2006). Disturbances in the break-
down of stored fat (endogenous lipolysis) may be a factor
contributing to an increased fat storage in the form of intra-
muscular triacylglycerol (IMTG) and lipid intermediates
(e.g. diacylglycerol (DAG), long-chain fatty-acyl CoA and
ceramides) (Blaak et al. 2004). The enzymatic regulation of
lipolysis in skeletal muscle is poorly understood, even in
healthy volunteers. The general view is that fat stores can be
mobilized by hormone-sensitive lipase (HSL), which is con-
trolled by the action of catecholamines (Langfort et al.
1999) and muscle contraction (Langfort et al. 2000).
Recently the identiWcation of a new lipase that is primarily
responsible for the hydrolysis of TAG was reported, namely
adipose triglyceride lipase (ATGL) (Zimmermann et al.
2004). ATGL mRNA expression has been demonstrated in
skeletal muscle of rodents (Zimmermann et al. 2004). Inter-
estingly, this lipase may play a pivotal role in skeletal mus-
cle lipolysis, since ATGL deWcient animals show signiWcant
TAG accumulation in non-adipose tissues, including skele-
tal muscle (Haemmerle et al. 2006). However, until now, it
is still unknown whether ATGL protein is expressed in
human skeletal muscle. Therefore, the aim of the present
study was to investigate whether ATGL is expressed at the
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protein level in human skeletal muscle. In addition, we
examined whether ATGL protein expression is Wber type-
speciWc to obtain better insight into its physiological role in
human skeletal muscle. To accomplish this we established a
combined immunohistochemical an immunoXuorescent
staining procedure to study ATGL protein expression in
relation to Wber type in human vastus lateralis muscle.
Materials and methods
Subjects
Skeletal muscle biopsies were taken under local anesthesia
(Xylocaine®, AstraZeneca BV, Zoetermeer, The Nether-
lands) by needle biopsy from the vastus lateralis muscle of
eight male subjects after an overnight fast. Three lean
(BMI < 25 kg/m2) and Wve obese (BMI > 30 kg/m2) male
subjects participated in this study. Anthropometric and
clinical data of the subjects are summarized in Table 1. Muscle
tissue was immediately frozen in isopentane, followed by
liquid nitrogen, and stored at ¡80°C until further analysis.
All subjects were asked to refrain from drinking alcohol
and to perform no strenuous exercise for a period of 24 h
prior to the biopsy. After subjects voided their bladder body
weight was determined on a calibrated electronic scale,
accurate to 0.1 kg. Waist and hip circumference measure-
ments to the nearest 1 cm were made midway between the
lower rib and iliac crest with participants standing upright.
Body weight and body density (by hydrostatic weighing)
used for calculations of percentage body fat (%BF), fat
mass (FM) and fat-free mass (FFM), were determined as
previously described (Goossens et al. 2007). Insulin sensi-
tivity was assessed by the homeostasis model assessment
index for insulin resistance (HOMAIR), calculated from
fasting glucose and insulin concentrations (Matthews et al.
1985). The Medical Ethical Review Committee of Maas-
tricht University approved the study protocol and the clini-
cal investigations were performed according to the
Declaration of Helsinki. All subjects gave their written
informed consent before participating in the study.
Biochemical analysis
A fasting venous blood sample was collected in tubes con-
taining EDTA as anti-coagulant and centrifuged for 10 min
at 1,000g, 4°C. The plasma was used for the enzymatic
colorimetric quantiWcation of glucose concentration (ABX
Diagnostics, Montepellier, France) on a COBAS MIRA
automated spectrophotometer (Roche Diagnostica, Basel,
Switzerland). Plasma insulin was measured with a double
antibody radioimmunoassay (Linco Research Inc., St.
Charles, Missouri, USA).
Immunostaining and immunoXuorescence protocol
Transverse serial sections (10 m) were cut from each
biopsy and each section was placed on a glass slide (Men-
zel GmbH & CoKG, Braunschweig, Germany) and air
dried at room temperature. Skeletal muscle ATGL protein
expression and Wber type were investigated by means of a
combined immunostaining and immunoXuorescence proto-
col. The sections were Wxed using 0.3% H2O2 in methanol.
After washing with phosphate buVered saline (PBS) the
sections were incubated overnight with a polyclonal anti-
body raised against human ATGL (Cayman Chemical,
Michigan, USA) in PBS at room temperature. Thereafter,
slides were incubated with a biotin labeled swine-anti-rab-
bit secondary antibody (DAKO, Glostrup, Denmark). Sub-
sequently, slides were washed with 0.05% Tween in PBS
and incubated with the ABC peroxidase kit (Vectastain
Elite PK610, Vector, Burlingame, California). The ATGL
immunostaining was visualized with diaminobenzidin
(DAB) solution (Fluka Chemie, GmbH, Buchs, Germany)
diluted in 0.05M Tris, pH 7.6 and 0.03% H2O2. Coloring
was followed by microscope and stopped with water. For
determining muscle Wber type the same slides were brieXy
washed in PBS and then incubated with a monoclonal anti-
body raised against adult human slow myosin heavy chain
and a monoclonal antibody reactive with adult human fast
IIa myosin heavy chain (Cho et al. 1993). The antibodies
were diluted in PBS and incubated at room temperature.
The following secondary antibodies were used: goat anti-
mouse IgM conjugated with Alexa Fluor 555 (red)
(GAMIgM-Alexa555) and goat anti-mouse IgG1 conju-
gated with Alexa Fluor 488 (green) (GAMIgG1-Alexa488;
Molecular Probes Europe, Leiden, The Netherlands), diluted
in PBS and incubated at room temperature. Finally, nuclei
were colored using Haematoxilin and slides were included
in Mowiol (Merck Chemicals Ltd., Nottingham, UK).
Table 1 Athropometric and clinical data for the subjects
Data are presented as mean § standard error (SE) and (range)
n Number of subjects, BMI body mass index, %BF percentage body
fat, FM fat mass, FFM fat-free Mass, WHR waist-to-hip ratio, HOMAir
homeostasis model assessment for insulin resistance
n Eight men 
(three lean and Wve obese)
Age (year) 50 § 3 (38–59)
BMI (kg/m2)2 8 . 9 § 1.9 (21.0–34.5)
%BF 28.9 § 1.7 (22.2–34.2)
FM (kg) 26.6 § 3.1 (16.5–40.3)
FFM (kg) 65.2 § 2.8 (53.3–77.6)
WHR 0.96 § 0.02 (0.85–1.06)
HOMAir 3.05 § 0.4 (1.6–4.1)Histochem Cell Biol (2008) 129:535–538 537
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Sections were viewed and photographed using a Nikon
Eclipse E800 microscope mounted with an Axiocam color
CCD camera (Nikon, Melville, NY USA). About 200 to
300 muscle Wbers were analyzed per person.
Results
Antropometric and clinical data for the subjects are summa-
rized in Table 1.
ATGL protein expression and Wber typing 
in human skeletal muscle
We found that ATGL protein is expressed in skeletal mus-
cle of both lean and obese subjects, respectively (visualized
as brown DAB staining in Fig. 1a, b). This observation was
representative for all lean (BMI < 25 kg/m2,  n =3 )  a n d
obese (BMI > 30 kg/m2, n = 5) subjects. Pre-incubation of
the ATGL antibody with the ATGL peptide or incubation
of the slides without ATGL antibody resulted in the com-
plete disappearance of this staining, indicating that this
staining is highly ATGL speciWc (data not shown). The
dual-immunoXuorescent staining of skeletal muscle Wbers
is shown in Fig. 1c (lean subjects) and d (obese subjects).
Type I Wbers stained red and type IIa Wbers stained green;
type IIx Wbers were unstained. When these images were
combined, it appeared that ATGL is expressed exclusively
in type I Wbers of both lean and obese subjects. All type I
Wbers stained positive for ATGL. None of the type II Wbers
showed a positive staining for ATGL.
Discussion
The present study examined ATGL protein expression in
human skeletal muscle for the Wrst time. The major Wnding
is that ATGL protein is exclusively expressed in type I oxi-
dative Wbers of human skeletal muscle.
It is known that type I (slow-twitch, oxidative) muscle
Wbers have an increased TAG content compared to type IIa
and IIx (fast-twitch, oxidative-glycolytic, predominantly gly-
colytic) Wbers (Malenfant et al. 2001). The present Wnding
that ATGL protein is exclusively expressed in type I Wbers of
human skeletal muscle, characterized by high TAG content
compared with type II Wbers, may suggest that ATGL plays
an important role in intramuscular fatty acid handling and
TAG turnover in humans. It has previously been shown that
HSL is also expressed in human skeletal muscle (RoepstorV
et al. 2004). Although HSL expression is not Wber type spe-
ciWc, higher levels are also found in type I Wbers (Langfort
et al. 1999). Taken together, the physiological role of ATGL
in skeletal muscle lipolysis certainly warrants further investi-
gation, both in healthy volunteers and in obese insulin resis-
tant subjects. It is tempting to speculate that an imbalance
between ATGL and HSL expression might increase the stor-
Fig. 1 Immunohistochemical ATGL staining combined by immuno-
Xuorescent Wber typing in skeletal muscle of a lean (BMI: 21.0 kg/m2,
a, c) and an obese (BMI: 32.4 kg/m2, b, d) subject. a, b Muscle Wbers
that contain ATGL stained brown using DAB (Wbers positively stained
for ATGL are indicated by an asterisk). c, d Dual-immunoXuorescent
staining of muscle Wbers; type I muscle Wbers stained red (indicated by
I), type IIa muscle Wbers stained green and type IIx muscle Wbers were
unstained (indicated by X). Images are of the same area of the same
section from the same lean (a, c) or obese (b, d) individual and dem-
onstrate that ATGL is expressed exclusively in type I muscle Wbers538 Histochem Cell Biol (2008) 129:535–538
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age of TAG or lipid intermediates in skeletal muscle of obese
insulin resistant subjects. In addition, it should be examined
whether a possible impairment can be reversed by interven-
tions, such as weight loss or physical activity that improve
insulin sensitivity.
In summary, the present data show for the Wrst time that
ATGL protein is present in human skeletal muscle, and is
exclusively expressed in type I muscle Wbers. ATGL may
play a pivotal role in skeletal muscle fatty acid handling,
lipid storage and lipolysis. These data indicate that there is
an urgent need to revisit lipolysis in human skeletal muscle.
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